SCHEMBL13857231

SCHEMBL13857231

O=COc1ccccc1/C=C/C(=O)c1cc2ccccc2oc1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.67
MAOA P21397 2/20 0.52
ALDH1A1 P00352 6/20 0.51
KMT2A Q03164 4/20 0.51
RAB9A P51151 3/20 0.51
NPC1 O15118 2/20 0.51
MAPT P10636 2/20 0.51
HTT P42858 2/20 0.51
GPR55 Q9Y2T6 1/20 0.51
HPGD P15428 3/20 0.50
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NTSR1 P30989 1/20 0.50
CA12 O43570 2/20 0.49
CA9 Q16790 2/20 0.49
CA1 P00915 1/20 0.49
CA3 P07451 1/20 0.49
TSHR P16473 1/20 0.49
CA4 P22748 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28458698 0.87 MAOB (0.69) MAOBMAOAALDH1A1KMT2ARAB9A
SCHEMBL28458699 0.87 MAOB (0.69) MAOBMAOAALDH1A1KMT2ARAB9A
SCHEMBL28245355 0.82 MAOB (0.75) MAOBKMT2ARAB9ANPC1MAPT
SCHEMBL28245359 0.82 MAOB (0.75) MAOBKMT2ARAB9ANPC1MAPT
SCHEMBL28458739 0.81 MAOB (1.00) MAOBMAOAALDH1A1KMT2ANPC1
SCHEMBL28458708 0.81 MAOB (0.73) MAOBMAOAALDH1A1KMT2ARAB9A
SCHEMBL28459080 0.81 MAOB (0.73) MAOBMAOAALDH1A1KMT2ARAB9A
SCHEMBL28459079 0.81 MAOB (0.73) MAOBMAOAALDH1A1KMT2ARAB9A
SCHEMBL13318682 0.79 MAOB (0.67) MAOBMAOAALDH1A1RAB9ANPC1
SCHEMBL13857227 0.79 MAOB (0.52) MAOBMAOAALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124688-A1 Prostaglandin reductase inhibitors ABGENOMICS CORPORATION (TW) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124688-A1 Prostaglandin reductase inhibitors PTGIR, PTGDR, PTGDR2 MAOB 1414/4885MAOA 1881/4885ALDH1A1 560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.